TY - JOUR
T1 - Vitamin B12, folate, and homocysteine levels in children and adolescents with obesity
T2 - a systematic review and meta-analysis
AU - Ulloque-Badaracco, Juan R.
AU - Alarcon-Braga, Esteban A.
AU - Hernandez-Bustamante, Enrique A.
AU - Von-Koeller-Jones, Beatrix M.
AU - Huayta-Cortez, Miguel
AU - Saavedra-Custodio, Esduardo
AU - Herrera-Añazco, Percy
AU - Benites-Zapata, Vicente A.
N1 - Publisher Copyright:
Copyright © 2025 Ulloque-Badaracco, Alarcon-Braga, Hernandez-Bustamante, Von-Koeller-Jones, Huayta-Cortez, Saavedra-Custodio, Herrera-Añazco and Benites-Zapata.
PY - 2025
Y1 - 2025
N2 - Background and aims: Childhood and adolescent obesity is a global public health concern. Obesity induces several metabolic disturbances. Several studies have explored the association of vitamin B12, folate, and homocysteine (Hcy) with obesity. This study aimed to synthesize the available evidence regarding the differences in serum levels of vitamin B12, Hcy, and folate among children or adolescents with and without obesity. Methods: A random-effects meta-analysis using the Sidik-Jonkman method and corrected 95% confidence interval (CI) using the truncated Knapp-Hartung standard errors was used for all meta-analyses. Standardized mean difference (SMD) with the corresponding 95% CI was used as the only effect size. The Cochran’s Q test and the I2 statistic were used to evaluate between-study heterogeneity. Publication bias was assessed using funnel plots and the Egger test. Results: Twenty studies were included with a combined study population of 7,791 patients. There were no significant differences between children/adolescents with and without obesity with respect to serum vitamin B12 levels (SMD: −0.24; 95% CI: −0.53 to 0.06; p > 0.05, I2 = 74.93%) and folate levels (SMD: −0.12; 95% CI: −0.29 to 0.06; p > 0.05, I2 = 19.6%). However, children/adolescents with obesity had significantly higher Hcy levels compared to counterparts without obesity (SMD: 0.77; 95% CI: 0.39 to 1.14; p < 0.001, I2 = 86.4%). Conclusion: Children and adolescents with obesity had higher Hcy levels than those without obesity. However, no significant differences were found for vitamin B12 and folate levels. Hcy may play a role in the development of obesity in this population.
AB - Background and aims: Childhood and adolescent obesity is a global public health concern. Obesity induces several metabolic disturbances. Several studies have explored the association of vitamin B12, folate, and homocysteine (Hcy) with obesity. This study aimed to synthesize the available evidence regarding the differences in serum levels of vitamin B12, Hcy, and folate among children or adolescents with and without obesity. Methods: A random-effects meta-analysis using the Sidik-Jonkman method and corrected 95% confidence interval (CI) using the truncated Knapp-Hartung standard errors was used for all meta-analyses. Standardized mean difference (SMD) with the corresponding 95% CI was used as the only effect size. The Cochran’s Q test and the I2 statistic were used to evaluate between-study heterogeneity. Publication bias was assessed using funnel plots and the Egger test. Results: Twenty studies were included with a combined study population of 7,791 patients. There were no significant differences between children/adolescents with and without obesity with respect to serum vitamin B12 levels (SMD: −0.24; 95% CI: −0.53 to 0.06; p > 0.05, I2 = 74.93%) and folate levels (SMD: −0.12; 95% CI: −0.29 to 0.06; p > 0.05, I2 = 19.6%). However, children/adolescents with obesity had significantly higher Hcy levels compared to counterparts without obesity (SMD: 0.77; 95% CI: 0.39 to 1.14; p < 0.001, I2 = 86.4%). Conclusion: Children and adolescents with obesity had higher Hcy levels than those without obesity. However, no significant differences were found for vitamin B12 and folate levels. Hcy may play a role in the development of obesity in this population.
KW - folate
KW - homocysteine
KW - meta-analysis
KW - obesity
KW - vitamin B12
UR - http://www.scopus.com/inward/record.url?scp=85219346919&partnerID=8YFLogxK
U2 - 10.3389/fpubh.2025.1481002
DO - 10.3389/fpubh.2025.1481002
M3 - Artículo de revisión
AN - SCOPUS:85219346919
SN - 2296-2565
VL - 13
JO - Frontiers in Public Health
JF - Frontiers in Public Health
M1 - 1481002
ER -